Intrinsic Value of S&P & Nasdaq Contact Us

Ginkgo Bioworks Holdings, Inc. DNA NYSE

NYSE • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.84
+1.6%

Stock Statistics — DNA

Ginkgo Bioworks Holdings, Inc. (DNA) has a market capitalization of $478.06M and trades at $7.72. The 52-week range is 5.05-17.58.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.4, Earnings Per Share (EPS) of $-5.64, annual revenue of $170.16M.

The stock has a beta of 1.57, operates in the Healthcare sector.

Trading Data
Current Price$7.72
52-Week Range5.05-17.58
Volume2.01M
Avg Volume (30D)1.16M
Market Cap$478.06M
Beta (1Y)1.57
Company
IPO Date2021-04-19
Employees834
CEOJason Kelly
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS37611X2099
CUSIP37611X209
Income (Latest Year)
Revenue$170.16M
Gross Profit$138.63M
EBITDA$-254.61M
Operating Income$-315.28M
Net Income$-312.76M
EPS$-5.64
EPS Diluted$-5.64
Shares Outstanding$55.46M
Balance Sheet (Latest Year)
Total Assets$1.12B
Current Assets$471.84M
Cash & ST Investments$422.62M
Total Liabilities$611.11M
Total Debt$417.08M
Net Debt$249.88M
Total Equity$508.59M
Debt / Equity0.82
Valuation Ratios
P/E Ratio-1.4
P/S Ratio2.81
P/B Ratio0.94
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message